Malignant Retroperitoneal Neoplasm — Trials

Malignant Retroperitoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 23
Ph III recruiting: 1
Growth YoY: —
Industry share: 5%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (17)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04031677	Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma(STRASS2)	recruiting	Phase 3	250	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	15	Sep 10, 2026	clinicaltrials
NCT00924989	A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma(GALACCTIC)	completed	Phase 3	139	Astellas Pharma IncINDUSTRY